HomeCompareSHLX vs PFE

SHLX vs PFE: Dividend Comparison 2026

SHLX yields 60.75% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $19.0K in total portfolio value· pulled ahead in Year 10
10 years
SHLX
SHLX
● Live price
60.75%
Share price
$15.82
Annual div
$9.61
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.1K
Annual income
$9.66
Full SHLX calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — SHLX vs PFE

📍 PFE pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHLXPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHLX + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHLX pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHLX
Annual income on $10K today (after 15% tax)
$5,163.96/yr
After 10yr DRIP, annual income (after tax)
$8.21/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $23,120.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHLX + PFE for your $10,000?

SHLX: 50%PFE: 50%
100% PFE50/50100% SHLX
Portfolio after 10yr
$41.6K
Annual income
$13,610.10/yr
Blended yield
32.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SHLX
Analyst Ratings
4
Buy
7
Hold
4
Sell
Consensus: Hold
Price Target
$16.00
+1.1% upside vs current
Range: $16.00 — $16.00
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHLX buys
0
PFE buys
0
No recent congressional trades found for SHLX or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHLXPFE
Forward yield60.75%6.20%
Annual dividend / share$9.61$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$32.1K$51.1K
Annual income after 10y$9.66$27,210.54
Total dividends collected$7.3K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold
Analyst price target$16.00$27.50

Year-by-year: SHLX vs PFE ($10,000, DRIP)

YearSHLX PortfolioSHLX Income/yrPFE PortfolioPFE Income/yrGap
1$13,738$3,037.63$9,161$701.38+$4.6KSHLX
2$16,649$1,949.99$8,610$859.79+$8.0KSHLX
3$18,919$1,104.34$8,366$1,081.25+$10.6KSHLX
4$20,830$586.40$8,483$1,405.66+$12.3KSHLX
5$22,590$301.69$9,084$1,907.24+$13.5KSHLX
6$24,324$152.89$10,418$2,732.78+$13.9KSHLX
7$26,103$76.93$13,007$4,193.56+$13.1KSHLX
8$27,969$38.58$18,010$7,005.87+$10.0KSHLX
9$29,946$19.32$28,216$12,979.89+$1.7KSHLX
10← crossover$32,052$9.66$51,081$27,210.54$19.0KPFE

SHLX vs PFE: Complete Analysis 2026

SHLXStock

Shell Midstream Partners, L.P. owns, operates, develops, and acquires pipelines and other midstream, and logistics assets in the United States. It owns interests in crude oil and refined products pipelines and terminals to transport onshore and offshore crude oil production to Gulf Coast and Midwest refining markets. The company stores and transports crude oil, refined, natural gas, and refinery gas products for various customers, including producers, refiners, marketers, and traders, as well as to other crude oil and refined products pipelines through its pipelines and storage tanks. Shell Midstream Partners GP LLC serves as the general partner of Shell Midstream Partners, L.P. The company was incorporated in 2014 and is headquartered in Houston, Texas. Shell Midstream Partners, L.P. is a subsidiary of Shell Pipeline Company LP.

Full SHLX Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SHLX vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHLX vs SCHDSHLX vs JEPISHLX vs OSHLX vs KOSHLX vs MAINSHLX vs JNJSHLX vs MRKSHLX vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.